European Commission Issues New GMP Guidelines for Advanced Therapies

International Pharmaceutical Regulatory Monitor
A A
The European Commission released new GMP guidelines for manufacturers of advanced therapy medicinal products that adapts existing European Union GMP guidelines to the specific characteristics of ATMPs and calls for a risk-based approach.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor